Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Skronski, P. Jagus, R. Langfort, A. Szpechcinski, K. Maszkowska-Kopij, B. Roszkowska-Sliz, J. Grudny, J. Zaleska, T. Orlowski, K. Roszkowski-Sliz, J. Chorostowska-Wynimko (Warsaw, Poland). Validation of PNA-LNA PCR clamp assay for detection of EGFR exon 19 and 21 mutations in various types of clinical non-small cell lung cancer specimens. Eur Respir J 2013; 42: Suppl. 57, 544

Member's Comments

No comment yet.

Related content which might interest you: Allele-specific real-time PCR detection of EGFR exon 19 and 21 mutations in various clinical non-small cell lung cancer specimens Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Quantitative detection of ALK rearrangements using droplet digital PCR (ddPCR) in liquid biopsies of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016 Noninvasive detection of EGFR T790M mutation in gefitinib resistant non-small cell lung cancer using mutant-enriched PCR Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Cytological samples for the study of EGFR, KRAS and ALK mutations in non-small cell lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 RT-PCR expression of EML4-ALK oncogene in Bulgarian patients with non-small cell lung cancers Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 RT-PCR and IHC as the alternative methods for detection of ALK aberrations in NSCLC samples - The feasibility study Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 A tissue microarray analysis on the role of chromosome 7 multiplication regarding the EGFR expression in non-small cell lung carcinomas Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Expression analysis of miR-21 in Bulgarian patients with non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Prognostic value of survivin gene promoter polymorphisms in non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 EGFRmutations are associated with higher brain metastasis radio-sensitivity than KRAS mutations or wild type EGFR in non-small cell lung cancer patients (NSCLC) Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Comparative analysis of lung cancer driver mutations from FFPE samples and liquid biopsies by IonTorrent next generation sequencing Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practice Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Frequency and type of EGFR mutations in patients with adenocarcinoma of the lung Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Optimization of cfDNA routine use for NSCLC genomic alteration analysis Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 RET fusion genes in Korean non-small cell lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Prevalence of mutations in Romanian patients with non-squamous lung carcinoma evaluated through next generation sequencing Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Automated target-FISH lung cancer detection (LCD) test of induced sputum Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014